Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 717 results for "fda centre for drug evaluation and re..."

US FDA approves AbbVie's Humira to treat patients with moderat...

The US Food and Drug Administration (FDA) has approved AbbVie's Humira (adalimumab) for reducing signs and symptoms, and achieving and maintaining clinical remission, in paediatric Crohn's disease patients 6 years of age and older when certain other ... PharmaBiz, 4 days ago
[x]  

4 images for fda centre for drug evaluation and research

OncLive, 3 weeks ago
Reuters, 2 months ago
Business Day Nigeria, 2 months ago
OncLive, 5 months ago

Appraisal of evidence base for introduction of new implants in hip and knee replacement: a systematic review of five widely used device technologies

Marc J Nieuwenhuijse , research fellow ICOR and FDA 1 2 3 , R G H H Nelissen , professor 2 , J W Schoones , information specialist 4 , A Sedrakyan , associate professor 1 3 1 Patient Centered Comparative Effectiveness Program and US Food and Drug ...
 British Medical Journal3 weeks ago

Pfizer seeks US FDA nod for palbociclib in combo with letrozole to treat women with ER+, HER2- advanced breast cancer

Pfizer has completed the submission of a New Drug Application (NDA) to the United States Food and Drug Administration (US FDA) for palbociclib. This NDA requests FDA approval of palbociclib, in combination with letrozole, for the treatment of ...
 PharmaBiz1 month ago
International Business Times UK

Ruxolitinib: FDA-Approved Cancer Drug 'Cures' Alopecia in Four Months

Woman with alopecia, for which there is currently no cure or treatment (Lovebug11768) A drug approved by the US Food and Drugs Administration has been found to "cure" alopecia in just a few months. Ruxolitinib is a Janus kinase inhibitor, also ...
 International Business Times UK1 month ago

US FDA issues draft norms on regulatory submissions in electronic format, industry lauds move

The US Food and Drug Administration (FDA) has issued a draft guidance for the pharma and biotechnology industry to provide regulatory submissions in electronic format. This would be related to certain human pharmaceutical product applications. The ...
 PharmaBiz2 months ago

Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology

Key evaluation to inform the US Food and Drug Administration regulatory submission Prominent urology trials consortium The CUSP Group LLC to oversee study of the MiStat technology Initial pilot investigation will be followed by larger pivotal ...
 Asian Hospital & Healthcare Management1 week ago
[x]  

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

NEW YORK, Sept. 4, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: This BCC Research report provides detailed product analyses within health and wellness subsegments to overall ...
 Reliance Trust3 weeks ago Needle-Free Delivery: Technology and Market Forecast 2014-2024  Biotechgate1 month ago
[x]  

National Institutes of Health to fund next phase of Tissue Chip for Drug Screening programme

The National Institutes of Health (NIH) will award funds to support the next phase of its Tissue Chip for Drug Screening programme to improve ways of predicting drug safety and effectiveness. Researchers will collaborate over three years to refine ...
 PharmaBiz5 days ago

Our products meet the statutory and regulatory requirements of the EU

More than five decades old, Mumbai-based manufacturer of laboratory/ magnetic stirrers and centrifuges, and blood bank refrigerators/freezers, Remi Elektrotechnik has crossed several milestones since inception. With a small manufacturing unit in ...
 Express Pharma1 week ago

Amgen presents data from phase 3 SHIFT study evaluating ivabradine in patients with chronic HF at HFSA

Amgen announced data from the phase 3 SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18th Annual Scientific Meeting of the ...
 PharmaBiz2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less